Found 7 matching trials
To Determine the Safety and Immunogenicity of an Oral(Whole Cell) Euvichol Cholera Vaccine in Healthy Adult Men
PHASE1To Determine the Safety and Immunogenicity of an Oral(Whole Cell) Euvichol ...
Location
Chungnam National University Hospital
Safety and Immunogenicity of a New Formulation of Euvichol®
PHASE3* Number of doses and intervals: Two doses, 2 weeks apart
* Method of admin...
Location
Multiple Locations
Trial to Evaluate Immunogenicity Non-Inferiority, Safety and Lot-to-Lot Consistency of Biovac OCV-S to Euvichol®-Plus
PHASE3This Phase I/III clinical trial is intended to establish the immunogenicity...
Location
Synergy Biomed Research Institute
Age-descending Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Adults and Children
PHASE2This phase II study is intended to determine the immunogenicity and safety ...
Location
KAVI-Institute of Clinical Research, University
Immune Response to a Delayed Second Dose of Oral Cholera Vaccine
PHASE4Immune response to a delayed second dose of oral cholera vaccine
A randomi...
To Evaluate the Efficacy (Immunogenicity) and Safety of Euvichol in Healthy Adults and Children
PHASE3The purpose of this study is to evaluate the efficacy (Immunogenicity) and ...
Location
Antonio D. Ligsay, MD
Extended Dosing Intervals Trial for Oral Cholera Vaccine, Kenya
PHASE4Background: Despite efforts to control cholera, outbreaks continue to occur...